Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for KLF8
Z-value: 12.82
Motif logo
Transcription factors associated with KLF8
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
KLF8
|
ENSG00000102349.18 | KLF8 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| KLF8 | hg38_v1_chrX_+_56232343_56232363 | 0.66 | 1.5e-28 | Click! |
Activity profile of KLF8 motif
Sorted Z-values of KLF8 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of KLF8
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 16.0 | 47.9 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 13.5 | 67.3 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 6.9 | 20.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 6.2 | 31.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 5.6 | 22.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 5.6 | 39.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 5.5 | 32.9 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 4.6 | 18.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 4.5 | 18.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 4.5 | 13.4 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
| 4.5 | 26.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 4.4 | 21.8 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 4.4 | 30.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 4.2 | 17.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 4.2 | 21.2 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 4.2 | 25.0 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 4.1 | 8.3 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 4.1 | 12.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 3.9 | 15.6 | GO:0035627 | ceramide transport(GO:0035627) |
| 3.9 | 11.7 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 3.9 | 27.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 3.9 | 15.4 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 3.8 | 11.5 | GO:0071848 | circadian temperature homeostasis(GO:0060086) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 3.8 | 11.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 3.7 | 11.0 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
| 3.7 | 3.7 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 3.7 | 33.0 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 3.6 | 18.2 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 3.6 | 14.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 3.6 | 17.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 3.5 | 10.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 3.5 | 7.0 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 3.5 | 10.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 3.4 | 24.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 3.4 | 10.2 | GO:0009386 | translational attenuation(GO:0009386) |
| 3.4 | 10.2 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 3.4 | 3.4 | GO:0043379 | memory T cell differentiation(GO:0043379) |
| 3.4 | 10.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 3.3 | 13.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 3.3 | 9.8 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 3.3 | 9.8 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 3.3 | 16.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 3.2 | 16.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 3.2 | 13.0 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 3.2 | 242.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 3.2 | 12.9 | GO:0071724 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 3.2 | 3.2 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 3.1 | 15.7 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 3.1 | 12.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 3.1 | 9.3 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 3.1 | 12.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 3.1 | 9.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 3.0 | 9.1 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 3.0 | 12.0 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 3.0 | 12.0 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 3.0 | 35.8 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 3.0 | 3.0 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 2.9 | 14.7 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 2.9 | 8.8 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 2.9 | 8.8 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 2.9 | 23.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 2.8 | 8.3 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 2.7 | 18.9 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 2.7 | 13.4 | GO:0005985 | sucrose metabolic process(GO:0005985) |
| 2.7 | 8.0 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 2.6 | 15.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 2.6 | 18.1 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 2.6 | 15.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 2.5 | 7.6 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 2.5 | 7.5 | GO:2001301 | cellular response to interleukin-13(GO:0035963) regulation of engulfment of apoptotic cell(GO:1901074) lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 2.4 | 9.8 | GO:0030806 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) |
| 2.4 | 7.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 2.4 | 7.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 2.4 | 21.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 2.4 | 7.2 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 2.4 | 7.2 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) protection from natural killer cell mediated cytotoxicity(GO:0042270) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
| 2.4 | 14.4 | GO:0016926 | protein desumoylation(GO:0016926) |
| 2.4 | 21.4 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
| 2.4 | 4.8 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 2.4 | 7.1 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 2.3 | 25.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 2.3 | 9.3 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 2.3 | 2.3 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 2.3 | 16.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 2.3 | 6.9 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 2.3 | 2.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 2.3 | 11.4 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 2.3 | 6.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 2.2 | 11.2 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 2.2 | 15.7 | GO:0045007 | depurination(GO:0045007) |
| 2.2 | 8.9 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 2.2 | 42.0 | GO:0015671 | oxygen transport(GO:0015671) |
| 2.2 | 6.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 2.2 | 6.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 2.2 | 21.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 2.2 | 8.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 2.2 | 8.7 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 2.2 | 6.5 | GO:0014813 | skeletal muscle satellite cell commitment(GO:0014813) |
| 2.2 | 6.5 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 2.1 | 4.2 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 2.1 | 12.7 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 2.1 | 4.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
| 2.1 | 8.4 | GO:0015942 | formate metabolic process(GO:0015942) |
| 2.1 | 16.8 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 2.1 | 8.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 2.1 | 6.2 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 2.1 | 16.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 2.0 | 2.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 2.0 | 6.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 2.0 | 4.1 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
| 2.0 | 6.1 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 2.0 | 6.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 2.0 | 6.0 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 2.0 | 14.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 2.0 | 6.0 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 2.0 | 6.0 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 2.0 | 11.9 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 2.0 | 9.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 2.0 | 6.0 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 2.0 | 5.9 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 2.0 | 27.5 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.9 | 1.9 | GO:2000416 | regulation of eosinophil migration(GO:2000416) negative regulation of eosinophil migration(GO:2000417) |
| 1.9 | 19.5 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 1.9 | 9.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 1.9 | 1.9 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 1.9 | 3.9 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
| 1.9 | 9.7 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 1.9 | 5.8 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 1.9 | 13.5 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 1.9 | 7.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.9 | 7.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 1.9 | 11.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.9 | 5.7 | GO:0060005 | vestibular reflex(GO:0060005) |
| 1.9 | 7.5 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 1.9 | 1.9 | GO:2001074 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 1.8 | 7.4 | GO:1903611 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 1.8 | 5.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 1.8 | 9.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.8 | 12.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 1.8 | 3.7 | GO:1902623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 1.8 | 16.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.8 | 5.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.8 | 14.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 1.8 | 5.3 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 1.7 | 8.7 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 1.7 | 8.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 1.7 | 34.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 1.7 | 3.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 1.7 | 3.4 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
| 1.7 | 5.1 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 1.7 | 3.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 1.7 | 28.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 1.7 | 5.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 1.7 | 5.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 1.7 | 5.0 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.7 | 1.7 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 1.7 | 1.7 | GO:0003245 | growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.7 | 5.0 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 1.7 | 36.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 1.7 | 13.2 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.6 | 8.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 1.6 | 3.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 1.6 | 11.4 | GO:0048241 | epinephrine transport(GO:0048241) |
| 1.6 | 3.3 | GO:0071221 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
| 1.6 | 4.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 1.6 | 4.9 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 1.6 | 17.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 1.6 | 6.4 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 1.6 | 12.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 1.6 | 22.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 1.6 | 9.5 | GO:0060168 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 1.6 | 20.4 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 1.6 | 9.4 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 1.6 | 4.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.6 | 1.6 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 1.5 | 128.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 1.5 | 7.6 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 1.5 | 3.0 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 1.5 | 3.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
| 1.5 | 4.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.5 | 4.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 1.5 | 1.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 1.5 | 1.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.5 | 5.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 1.5 | 16.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 1.5 | 7.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 1.5 | 4.4 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
| 1.5 | 4.4 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 1.5 | 8.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 1.5 | 7.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 1.4 | 8.7 | GO:1903232 | melanosome assembly(GO:1903232) |
| 1.4 | 4.3 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 1.4 | 14.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 1.4 | 2.9 | GO:0086053 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 1.4 | 5.7 | GO:0003431 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
| 1.4 | 1.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.4 | 5.7 | GO:0002118 | aggressive behavior(GO:0002118) |
| 1.4 | 4.2 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 1.4 | 17.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 1.4 | 4.2 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 1.4 | 11.3 | GO:0051414 | response to cortisol(GO:0051414) |
| 1.4 | 12.7 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 1.4 | 16.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 1.4 | 5.6 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 1.4 | 1.4 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.4 | 15.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 1.4 | 4.2 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 1.4 | 4.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 1.4 | 8.3 | GO:0061744 | motor behavior(GO:0061744) |
| 1.4 | 16.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 1.4 | 8.3 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 1.4 | 1.4 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 1.4 | 30.2 | GO:0097503 | sialylation(GO:0097503) |
| 1.4 | 5.5 | GO:0032571 | response to vitamin K(GO:0032571) |
| 1.4 | 9.6 | GO:0015705 | iodide transport(GO:0015705) |
| 1.4 | 2.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.4 | 12.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.4 | 1.4 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 1.3 | 4.0 | GO:2000374 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) regulation of oxygen metabolic process(GO:2000374) |
| 1.3 | 5.4 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 1.3 | 25.5 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 1.3 | 12.1 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) |
| 1.3 | 10.6 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 1.3 | 9.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 1.3 | 5.3 | GO:0060023 | soft palate development(GO:0060023) |
| 1.3 | 5.2 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 1.3 | 3.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 1.3 | 9.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.3 | 6.4 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 1.3 | 32.0 | GO:0007141 | male meiosis I(GO:0007141) |
| 1.3 | 12.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 1.3 | 54.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 1.3 | 3.8 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 1.3 | 2.5 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 1.3 | 5.0 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 1.3 | 5.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 1.3 | 5.0 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 1.2 | 6.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 1.2 | 5.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 1.2 | 34.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 1.2 | 11.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 1.2 | 3.7 | GO:1900060 | glucosylceramide biosynthetic process(GO:0006679) negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 1.2 | 6.1 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.2 | 2.5 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
| 1.2 | 4.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 1.2 | 1.2 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.2 | 12.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 1.2 | 1.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 1.2 | 1.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
| 1.2 | 12.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 1.2 | 4.8 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
| 1.2 | 3.6 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 1.2 | 1.2 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 1.2 | 2.4 | GO:0060214 | endocardium formation(GO:0060214) |
| 1.2 | 3.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 1.2 | 4.7 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 1.2 | 5.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 1.2 | 4.7 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 1.2 | 5.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) mesenchyme migration(GO:0090131) |
| 1.2 | 3.5 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.2 | 3.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 1.1 | 3.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 1.1 | 3.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 1.1 | 3.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.1 | 4.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 1.1 | 1.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
| 1.1 | 9.1 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
| 1.1 | 3.4 | GO:0071317 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 1.1 | 13.5 | GO:0015074 | DNA integration(GO:0015074) |
| 1.1 | 3.4 | GO:0050957 | equilibrioception(GO:0050957) |
| 1.1 | 13.5 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 1.1 | 4.5 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 1.1 | 10.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 1.1 | 4.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 1.1 | 4.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 1.1 | 5.5 | GO:0030242 | pexophagy(GO:0030242) |
| 1.1 | 4.4 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
| 1.1 | 4.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 1.1 | 4.3 | GO:1905225 | cellular response to glycoprotein(GO:1904588) response to thyrotropin-releasing hormone(GO:1905225) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 1.1 | 8.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.1 | 1.1 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 1.1 | 6.5 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 1.1 | 5.3 | GO:1901906 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 1.1 | 3.2 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 1.1 | 18.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 1.1 | 3.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 1.1 | 5.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 1.0 | 6.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 1.0 | 5.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 1.0 | 8.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 1.0 | 3.1 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.0 | 12.4 | GO:0070254 | mucus secretion(GO:0070254) |
| 1.0 | 6.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.0 | 7.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 1.0 | 2.1 | GO:1902617 | response to fluoride(GO:1902617) |
| 1.0 | 6.1 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.0 | 4.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 1.0 | 5.1 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 1.0 | 5.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 1.0 | 3.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 1.0 | 7.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 1.0 | 9.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 1.0 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
| 1.0 | 13.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 1.0 | 6.0 | GO:0033504 | floor plate development(GO:0033504) |
| 1.0 | 5.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 1.0 | 7.9 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 1.0 | 8.9 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 1.0 | 12.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 1.0 | 4.9 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 1.0 | 4.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 1.0 | 1.0 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) |
| 1.0 | 3.9 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.0 | 1.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 1.0 | 15.4 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 1.0 | 10.6 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 1.0 | 15.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 1.0 | 2.9 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 1.0 | 5.7 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 1.0 | 5.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 1.0 | 1.9 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 1.0 | 9.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 1.0 | 8.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 1.0 | 28.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.9 | 1.9 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.9 | 1.9 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.9 | 5.7 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
| 0.9 | 4.7 | GO:0046618 | drug export(GO:0046618) |
| 0.9 | 1.9 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.9 | 1.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.9 | 9.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.9 | 12.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.9 | 1.9 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.9 | 11.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.9 | 2.8 | GO:0090291 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of osteoclast proliferation(GO:0090291) |
| 0.9 | 6.5 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
| 0.9 | 2.8 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.9 | 6.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.9 | 3.7 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.9 | 1.9 | GO:0021586 | pons maturation(GO:0021586) |
| 0.9 | 5.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.9 | 3.7 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.9 | 15.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.9 | 5.5 | GO:0007497 | posterior midgut development(GO:0007497) |
| 0.9 | 6.4 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.9 | 1.8 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.9 | 9.1 | GO:0015824 | proline transport(GO:0015824) |
| 0.9 | 5.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.9 | 1.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.9 | 64.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
| 0.9 | 9.0 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.9 | 5.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.9 | 13.5 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.9 | 4.5 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.9 | 13.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.9 | 5.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.9 | 2.7 | GO:1905073 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.9 | 1.8 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.9 | 2.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.9 | 8.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.9 | 8.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.9 | 4.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.9 | 2.6 | GO:2000583 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.9 | 6.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.9 | 3.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.9 | 11.3 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 0.9 | 5.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.9 | 6.9 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.9 | 12.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.9 | 5.2 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.9 | 3.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.9 | 2.6 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.9 | 6.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.9 | 2.6 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.9 | 2.6 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.8 | 4.2 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.8 | 1.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.8 | 3.4 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.8 | 3.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.8 | 2.5 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.8 | 3.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.8 | 5.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 0.8 | 3.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.8 | 8.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.8 | 4.9 | GO:0022605 | ovarian cumulus expansion(GO:0001550) oogenesis stage(GO:0022605) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.8 | 51.3 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.8 | 13.0 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.8 | 4.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.8 | 10.5 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
| 0.8 | 8.9 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.8 | 7.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.8 | 1.6 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.8 | 4.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.8 | 4.8 | GO:0038016 | insulin receptor internalization(GO:0038016) |
| 0.8 | 1.6 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.8 | 2.4 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.8 | 8.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.8 | 3.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.8 | 1.6 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.8 | 12.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.8 | 1.6 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
| 0.8 | 4.7 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.8 | 14.8 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.8 | 0.8 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.8 | 3.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.8 | 7.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.8 | 2.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.8 | 3.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.8 | 3.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.8 | 3.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.8 | 3.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.8 | 6.1 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.8 | 4.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.8 | 2.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.8 | 1.5 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.8 | 3.0 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 0.8 | 4.5 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.8 | 0.8 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.8 | 6.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.8 | 6.0 | GO:0015747 | urate transport(GO:0015747) |
| 0.7 | 6.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.7 | 11.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.7 | 10.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.7 | 2.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) cellular amide catabolic process(GO:0043605) |
| 0.7 | 8.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.7 | 20.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.7 | 6.7 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 0.7 | 2.2 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.7 | 11.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
| 0.7 | 4.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.7 | 2.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.7 | 26.4 | GO:0048599 | oocyte development(GO:0048599) |
| 0.7 | 38.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.7 | 5.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.7 | 2.9 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.7 | 5.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.7 | 2.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.7 | 0.7 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.7 | 4.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.7 | 10.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.7 | 2.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.7 | 10.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.7 | 8.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.7 | 17.2 | GO:0097502 | mannosylation(GO:0097502) |
| 0.7 | 3.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.7 | 5.7 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.7 | 2.8 | GO:0010193 | response to ozone(GO:0010193) |
| 0.7 | 4.3 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.7 | 8.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.7 | 2.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.7 | 0.7 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.7 | 2.1 | GO:1903006 | regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
| 0.7 | 2.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.7 | 2.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.7 | 15.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.7 | 1.4 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.7 | 6.1 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.7 | 2.0 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.7 | 1.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.7 | 2.7 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.7 | 2.7 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.7 | 3.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.7 | 1.3 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.7 | 2.0 | GO:1900426 | positive regulation of synaptic vesicle priming(GO:0010808) positive regulation of defense response to bacterium(GO:1900426) |
| 0.7 | 1.3 | GO:1904640 | response to methionine(GO:1904640) |
| 0.7 | 5.4 | GO:0007135 | meiosis II(GO:0007135) |
| 0.7 | 3.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.7 | 7.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.7 | 2.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.7 | 3.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.7 | 17.9 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.7 | 1.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.7 | 3.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.7 | 4.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.7 | 1.3 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.7 | 5.9 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.7 | 2.0 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.7 | 2.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.6 | 5.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.6 | 6.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.6 | 13.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.6 | 5.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.6 | 3.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.6 | 2.6 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.6 | 1.9 | GO:0048370 | vacuolar phosphate transport(GO:0007037) lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.6 | 6.4 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.6 | 8.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.6 | 2.6 | GO:1901317 | regulation of sperm motility(GO:1901317) |
| 0.6 | 1.3 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.6 | 3.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.6 | 3.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.6 | 8.3 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
| 0.6 | 7.0 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.6 | 3.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.6 | 7.0 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.6 | 1.3 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.6 | 5.7 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.6 | 2.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.6 | 4.4 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.6 | 5.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.6 | 10.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.6 | 8.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.6 | 1.9 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.6 | 2.5 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.6 | 1.9 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 0.6 | 9.8 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 0.6 | 6.1 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.6 | 3.7 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.6 | 4.9 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 0.6 | 1.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.6 | 9.8 | GO:0060022 | hard palate development(GO:0060022) |
| 0.6 | 12.8 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.6 | 1.8 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.6 | 3.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.6 | 1.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.6 | 15.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.6 | 13.9 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.6 | 3.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.6 | 15.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.6 | 8.4 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.6 | 4.2 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.6 | 3.0 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.6 | 38.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.6 | 4.2 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.6 | 3.0 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.6 | 2.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.6 | 4.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.6 | 17.1 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.6 | 12.4 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.6 | 1.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
| 0.6 | 1.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.6 | 2.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.6 | 1.7 | GO:0090521 | regulation of embryonic cell shape(GO:0016476) glomerular visceral epithelial cell migration(GO:0090521) |
| 0.6 | 4.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.6 | 6.9 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.6 | 4.0 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.6 | 2.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.6 | 2.9 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.6 | 2.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.6 | 1.7 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.6 | 3.4 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.6 | 1.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.6 | 1.1 | GO:0042710 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.6 | 1.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.6 | 3.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.6 | 1.7 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.6 | 3.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.6 | 2.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.6 | 1.1 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.5 | 4.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.5 | 3.3 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.5 | 4.9 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.5 | 4.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 | 9.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
| 0.5 | 6.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.5 | 3.2 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.5 | 8.5 | GO:0051194 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.5 | 2.6 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.5 | 8.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.5 | 12.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.5 | 2.6 | GO:0060068 | vagina development(GO:0060068) |
| 0.5 | 3.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.5 | 12.3 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.5 | 4.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.5 | 6.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.5 | 1.0 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.5 | 2.0 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.5 | 33.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
| 0.5 | 4.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.5 | 7.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.5 | 1.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.5 | 4.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.5 | 8.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.5 | 1.0 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.5 | 1.0 | GO:1990834 | response to odorant(GO:1990834) |
| 0.5 | 0.5 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
| 0.5 | 2.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.5 | 2.0 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.5 | 1.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.5 | 1.9 | GO:1903974 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.5 | 2.4 | GO:0021936 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.5 | 3.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.5 | 7.2 | GO:0007140 | male meiosis(GO:0007140) |
| 0.5 | 1.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.5 | 7.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.5 | 1.4 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.5 | 4.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.5 | 2.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.5 | 1.4 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.5 | 0.9 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
| 0.5 | 6.1 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.5 | 20.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.5 | 2.8 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.5 | 8.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.5 | 1.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.5 | 8.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.5 | 1.4 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.5 | 5.6 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.5 | 5.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.5 | 2.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.5 | 3.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.5 | 1.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.5 | 1.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.5 | 0.9 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.4 | 2.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.4 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.4 | 3.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.4 | 11.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.4 | 5.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.4 | 6.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.4 | 4.4 | GO:0021756 | striatum development(GO:0021756) |
| 0.4 | 15.8 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.4 | 2.6 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.4 | 5.2 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.4 | 3.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.4 | 2.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.4 | 4.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.4 | 5.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.4 | 1.3 | GO:0000050 | urea cycle(GO:0000050) |
| 0.4 | 4.6 | GO:0046520 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.4 | 5.0 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.4 | 0.8 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.4 | 5.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.4 | 7.4 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.4 | 1.2 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.4 | 4.9 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.4 | 5.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.4 | 2.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.4 | 3.7 | GO:0060073 | micturition(GO:0060073) |
| 0.4 | 7.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.4 | 1.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.4 | 2.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.4 | 3.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 1.2 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.4 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.4 | 1.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.4 | 5.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.4 | 1.2 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.4 | 2.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.4 | 4.0 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.4 | 6.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.4 | 3.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.4 | 2.0 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
| 0.4 | 1.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.4 | 1.2 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.4 | 3.9 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
| 0.4 | 8.9 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.4 | 3.5 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.4 | 1.2 | GO:0099558 | motor learning(GO:0061743) maintenance of synapse structure(GO:0099558) |
| 0.4 | 1.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.4 | 5.0 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.4 | 12.0 | GO:0010518 | positive regulation of phospholipase activity(GO:0010518) |
| 0.4 | 5.0 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.4 | 1.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.4 | 3.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 | 3.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.4 | 1.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.4 | 3.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.4 | 3.4 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.4 | 2.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.4 | 2.3 | GO:0007320 | insemination(GO:0007320) |
| 0.4 | 1.9 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
| 0.4 | 3.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.4 | 2.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.4 | 1.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.4 | 5.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.4 | 2.6 | GO:0034505 | tooth mineralization(GO:0034505) |
| 0.4 | 0.4 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.4 | 1.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.4 | 3.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.4 | 1.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.4 | 3.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.4 | 1.8 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.4 | 5.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.4 | 5.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.4 | 9.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.4 | 4.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.4 | 1.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.4 | 1.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 | 4.9 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.3 | 3.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.3 | 3.5 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.3 | 16.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.3 | 1.7 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 | 3.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.3 | 8.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 | 2.4 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.3 | 2.7 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.3 | 1.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.3 | 2.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 | 1.7 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.3 | 1.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.3 | 6.6 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
| 0.3 | 1.6 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
| 0.3 | 18.9 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.3 | 12.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.3 | 4.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.3 | 6.1 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.3 | 12.5 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.3 | 1.3 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.3 | 1.0 | GO:0016137 | glycoside metabolic process(GO:0016137) |
| 0.3 | 1.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.3 | 5.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.3 | 6.9 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.3 | 2.8 | GO:0031269 | pseudopodium assembly(GO:0031269) |
| 0.3 | 0.9 | GO:2000342 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.3 | 2.5 | GO:0090102 | cochlea development(GO:0090102) |
| 0.3 | 4.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.3 | 8.4 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.3 | 3.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.3 | 3.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.3 | 2.1 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
| 0.3 | 3.8 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.3 | 0.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.3 | 4.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.3 | 0.6 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.3 | 3.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.3 | 1.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.3 | 4.0 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.3 | 1.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.3 | 2.0 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.3 | 1.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.3 | 5.4 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.3 | 2.5 | GO:0003407 | neural retina development(GO:0003407) |
| 0.3 | 6.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.3 | 1.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.3 | 4.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.3 | 1.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.3 | 1.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.3 | 1.9 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
| 0.3 | 1.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.3 | 2.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.3 | 18.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.3 | 0.8 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.3 | 2.4 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.3 | 3.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 | 3.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.3 | 2.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.3 | 2.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.3 | 3.9 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.3 | 25.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.3 | 17.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.3 | 1.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 1.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.3 | 1.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.3 | 0.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.3 | 2.5 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.2 | 14.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.2 | 4.9 | GO:0030317 | sperm motility(GO:0030317) |
| 0.2 | 1.0 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
| 0.2 | 2.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.2 | 2.0 | GO:1902116 | negative regulation of centriole replication(GO:0046600) negative regulation of organelle assembly(GO:1902116) |
| 0.2 | 2.7 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.2 | 0.7 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.2 | 1.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 0.5 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.2 | 2.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.2 | 1.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 | 2.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.2 | 1.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.2 | 1.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.2 | 0.7 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
| 0.2 | 0.7 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
| 0.2 | 2.7 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.2 | 0.7 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
| 0.2 | 3.4 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.2 | 5.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.2 | 2.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 | 0.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.2 | 8.0 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.2 | 15.8 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
| 0.2 | 30.1 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.2 | 1.9 | GO:0060411 | cardiac septum morphogenesis(GO:0060411) |
| 0.2 | 2.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.2 | 1.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.2 | 1.3 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) female genitalia development(GO:0030540) nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) |
| 0.2 | 1.1 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.2 | 0.6 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.2 | 0.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 | 3.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.2 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.2 | 1.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.2 | 1.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.2 | 1.8 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.2 | 2.9 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.2 | 0.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.2 | 1.1 | GO:0035331 | regulation of hippo signaling(GO:0035330) negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 1.1 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
| 0.2 | 2.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.2 | 2.4 | GO:0007616 | long-term memory(GO:0007616) |
| 0.2 | 0.7 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.2 | 0.5 | GO:0060748 | mammary gland branching involved in pregnancy(GO:0060745) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.2 | 5.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.2 | 4.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.2 | 0.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.2 | 1.6 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.2 | 1.0 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.2 | 0.3 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 | 2.7 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
| 0.2 | 1.0 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 | 3.1 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.2 | 1.0 | GO:0050433 | regulation of catecholamine secretion(GO:0050433) |
| 0.2 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.2 | 0.5 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.2 | 1.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 2.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.2 | 0.5 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.2 | 4.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.2 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 1.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.2 | 6.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.2 | 1.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.2 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.2 | 5.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 | 1.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.1 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.1 | 0.3 | GO:0033629 | abortive mitotic cell cycle(GO:0033277) negative regulation of cell adhesion mediated by integrin(GO:0033629) atrioventricular canal development(GO:0036302) negative regulation of growth hormone secretion(GO:0060125) intestinal epithelial cell migration(GO:0061582) |
| 0.1 | 1.6 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
| 0.1 | 1.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 1.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 | 3.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.1 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
| 0.1 | 1.0 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
| 0.1 | 1.7 | GO:0009798 | axis specification(GO:0009798) |
| 0.1 | 0.9 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.1 | 6.1 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 1.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.1 | 1.5 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.1 | 3.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 0.4 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.1 | 0.6 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.1 | 1.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 | 0.3 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 0.1 | 4.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.1 | 0.5 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.1 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 0.6 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 | 0.5 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
| 0.1 | 0.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 | 0.2 | GO:0071872 | response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) |
| 0.1 | 1.0 | GO:0060415 | muscle tissue morphogenesis(GO:0060415) |
| 0.1 | 0.9 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 8.7 | GO:0030072 | peptide hormone secretion(GO:0030072) |
| 0.1 | 0.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
| 0.1 | 0.5 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.1 | 7.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.1 | 1.0 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
| 0.1 | 0.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.2 | GO:0032095 | regulation of response to food(GO:0032095) |
| 0.1 | 1.2 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.1 | 0.3 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.1 | 4.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 6.0 | GO:0007586 | digestion(GO:0007586) |
| 0.1 | 0.5 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.1 | 1.6 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 1.0 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 0.1 | GO:0035788 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.1 | 0.7 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.1 | 0.5 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.1 | 1.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.1 | 0.6 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.1 | 0.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.1 | 1.6 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 1.3 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
| 0.1 | 0.5 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 1.0 | GO:0048477 | oogenesis(GO:0048477) |
| 0.1 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 0.5 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.1 | 1.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.1 | 1.4 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.1 | 1.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 | 0.9 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.3 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
| 0.1 | 0.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.3 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.1 | 1.8 | GO:0006024 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.1 | 2.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 3.7 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 0.0 | 0.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
| 0.0 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 0.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 | 1.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.0 | 0.6 | GO:0000045 | autophagosome assembly(GO:0000045) |
| 0.0 | 0.1 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 | 1.0 | GO:0098761 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 | 0.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 | 2.7 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
| 0.0 | 0.1 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.0 | 1.6 | GO:0007605 | sensory perception of sound(GO:0007605) |
| 0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.0 | 28.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 6.1 | 18.3 | GO:0071750 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
| 5.7 | 22.9 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 5.5 | 105.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 5.5 | 81.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 4.7 | 14.0 | GO:0036025 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 4.5 | 13.6 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 4.2 | 208.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 4.0 | 7.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 3.5 | 31.8 | GO:0033391 | chromatoid body(GO:0033391) |
| 3.4 | 20.5 | GO:0033269 | internode region of axon(GO:0033269) |
| 3.4 | 23.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 3.3 | 9.9 | GO:0008623 | CHRAC(GO:0008623) |
| 3.2 | 3.2 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 3.1 | 9.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 3.1 | 9.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 3.1 | 3.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 3.1 | 9.3 | GO:0070701 | mucus layer(GO:0070701) |
| 2.8 | 16.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 2.7 | 13.5 | GO:0072534 | perineuronal net(GO:0072534) |
| 2.6 | 5.2 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 2.6 | 15.6 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 2.5 | 7.5 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 2.5 | 7.4 | GO:0045298 | tubulin complex(GO:0045298) |
| 2.4 | 7.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 2.4 | 9.6 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 2.3 | 22.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 2.3 | 25.0 | GO:0043203 | axon hillock(GO:0043203) |
| 2.2 | 6.6 | GO:0060987 | lipid tube(GO:0060987) |
| 2.2 | 19.7 | GO:0071953 | elastic fiber(GO:0071953) |
| 2.1 | 8.6 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 2.1 | 8.2 | GO:0035363 | histone locus body(GO:0035363) |
| 2.0 | 16.1 | GO:0042583 | chromaffin granule(GO:0042583) |
| 1.9 | 3.9 | GO:0045179 | apical cortex(GO:0045179) |
| 1.9 | 34.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 1.9 | 7.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 1.9 | 5.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 1.9 | 17.0 | GO:0001520 | outer dense fiber(GO:0001520) |
| 1.8 | 5.5 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 1.8 | 9.0 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 1.8 | 12.6 | GO:0032010 | phagolysosome(GO:0032010) |
| 1.8 | 14.2 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 1.8 | 12.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 1.7 | 5.2 | GO:0098536 | deuterosome(GO:0098536) |
| 1.7 | 7.0 | GO:0042629 | mast cell granule(GO:0042629) |
| 1.7 | 10.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 1.7 | 10.0 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 1.7 | 30.0 | GO:0033270 | paranode region of axon(GO:0033270) |
| 1.6 | 21.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 1.6 | 16.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.6 | 29.4 | GO:0042627 | chylomicron(GO:0042627) |
| 1.6 | 6.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 1.6 | 9.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 1.6 | 6.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 1.6 | 4.7 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 1.5 | 7.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 1.5 | 14.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 1.4 | 8.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.4 | 4.3 | GO:0043293 | apoptosome(GO:0043293) |
| 1.4 | 8.4 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 1.4 | 4.2 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 1.4 | 5.5 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 1.4 | 5.5 | GO:0033263 | CORVET complex(GO:0033263) |
| 1.4 | 30.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 1.4 | 16.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 1.4 | 6.8 | GO:0036128 | CatSper complex(GO:0036128) |
| 1.3 | 10.8 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 1.3 | 5.3 | GO:0070695 | FHF complex(GO:0070695) |
| 1.3 | 5.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 1.3 | 13.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 1.3 | 4.0 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 1.3 | 2.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 1.3 | 11.8 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.3 | 13.0 | GO:0032009 | early phagosome(GO:0032009) |
| 1.3 | 20.1 | GO:0035102 | PRC1 complex(GO:0035102) |
| 1.2 | 5.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 1.2 | 2.5 | GO:0000805 | X chromosome(GO:0000805) |
| 1.2 | 11.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 1.2 | 3.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 1.2 | 6.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 1.2 | 11.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 1.2 | 5.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 1.2 | 21.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 1.2 | 47.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 1.1 | 8.0 | GO:0043196 | varicosity(GO:0043196) |
| 1.1 | 13.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 1.1 | 10.0 | GO:0097427 | microtubule bundle(GO:0097427) |
| 1.1 | 16.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 1.1 | 3.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 1.1 | 16.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 1.1 | 3.2 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 1.1 | 9.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 1.0 | 8.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 1.0 | 7.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 1.0 | 4.0 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 1.0 | 14.0 | GO:0000800 | lateral element(GO:0000800) |
| 1.0 | 5.0 | GO:0032449 | CBM complex(GO:0032449) |
| 1.0 | 5.0 | GO:0036398 | TCR signalosome(GO:0036398) |
| 1.0 | 7.8 | GO:0070187 | telosome(GO:0070187) |
| 0.9 | 29.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.9 | 4.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.9 | 31.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.9 | 3.7 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.9 | 10.9 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.9 | 4.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.9 | 1.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.9 | 13.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.9 | 4.4 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.9 | 6.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.9 | 60.1 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.9 | 6.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.9 | 4.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.9 | 4.3 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 0.9 | 4.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.8 | 2.5 | GO:0000801 | central element(GO:0000801) |
| 0.8 | 4.2 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.8 | 2.5 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.8 | 9.2 | GO:0042611 | MHC protein complex(GO:0042611) |
| 0.8 | 15.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.8 | 6.7 | GO:0072487 | MSL complex(GO:0072487) |
| 0.8 | 4.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.8 | 14.4 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.8 | 7.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.8 | 8.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.8 | 2.4 | GO:0097229 | sperm end piece(GO:0097229) |
| 0.8 | 3.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.8 | 3.0 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.7 | 6.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.7 | 5.9 | GO:0034464 | BBSome(GO:0034464) |
| 0.7 | 11.0 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.7 | 11.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.7 | 3.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.7 | 5.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.7 | 7.1 | GO:0031045 | dense core granule(GO:0031045) |
| 0.7 | 10.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.7 | 2.8 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.7 | 2.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.7 | 11.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.7 | 24.6 | GO:1902710 | GABA receptor complex(GO:1902710) |
| 0.7 | 5.9 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.7 | 3.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.6 | 3.8 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.6 | 12.8 | GO:0016342 | catenin complex(GO:0016342) |
| 0.6 | 4.4 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.6 | 11.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.6 | 1.9 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.6 | 1.8 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.6 | 4.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.6 | 1.8 | GO:0099569 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 0.6 | 2.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.6 | 39.1 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.6 | 14.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.6 | 3.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.6 | 1.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 0.6 | 13.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.6 | 10.7 | GO:0036038 | MKS complex(GO:0036038) |
| 0.6 | 6.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.6 | 6.1 | GO:0070449 | elongin complex(GO:0070449) |
| 0.6 | 2.8 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.6 | 1.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.5 | 7.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.5 | 11.5 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
| 0.5 | 7.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.5 | 34.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.5 | 1.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.5 | 2.1 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.5 | 3.1 | GO:0005883 | neurofilament(GO:0005883) |
| 0.5 | 1.5 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.5 | 61.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.5 | 4.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.5 | 4.4 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.5 | 5.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.5 | 6.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.5 | 7.3 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.5 | 3.4 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.5 | 4.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.5 | 5.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.5 | 5.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.5 | 5.2 | GO:0043218 | compact myelin(GO:0043218) |
| 0.5 | 2.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.5 | 5.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.5 | 3.2 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.4 | 34.8 | GO:0005901 | caveola(GO:0005901) |
| 0.4 | 4.9 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.4 | 2.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.4 | 2.2 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.4 | 6.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.4 | 1.3 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.4 | 0.9 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.4 | 61.2 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.4 | 13.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.4 | 14.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.4 | 5.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.4 | 5.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.4 | 7.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.4 | 16.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.4 | 25.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.4 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.4 | 3.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.4 | 6.9 | GO:0005922 | connexon complex(GO:0005922) |
| 0.4 | 6.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.4 | 3.4 | GO:0045180 | basal cortex(GO:0045180) |
| 0.4 | 7.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.4 | 1.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.4 | 4.7 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.4 | 5.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.3 | 1.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.3 | 29.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.3 | 33.5 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.3 | 4.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.3 | 36.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.3 | 0.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.3 | 1.9 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.3 | 8.7 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.3 | 1.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.3 | 5.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.3 | 1.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.3 | 3.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.3 | 4.7 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.3 | 4.1 | GO:0000145 | exocyst(GO:0000145) |
| 0.3 | 2.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.3 | 6.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.3 | 6.6 | GO:0005902 | microvillus(GO:0005902) |
| 0.3 | 3.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.3 | 26.9 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.3 | 1.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.3 | 5.5 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.3 | 1.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.3 | 1.3 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 3.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 1.2 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 62.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.2 | 1.1 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.2 | 4.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.2 | 18.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.2 | 29.3 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.2 | 5.2 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 29.2 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.2 | 1.0 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.2 | 1.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.2 | 2.8 | GO:0097546 | ciliary base(GO:0097546) |
| 0.2 | 7.3 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.2 | 6.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.2 | 1.0 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.2 | 0.8 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.2 | 0.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.2 | 7.8 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.2 | 22.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.2 | 7.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.2 | 1.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.2 | 2.8 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 0.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.1 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
| 0.1 | 2.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 0.5 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.1 | 2.4 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 12.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 550.5 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
| 0.1 | 1.2 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 1.8 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 6.2 | GO:0031514 | motile cilium(GO:0031514) |
| 0.1 | 0.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.1 | 4.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 1.4 | GO:0005861 | troponin complex(GO:0005861) |
| 0.1 | 3.2 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 75.8 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.1 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.0 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.4 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.0 | 1.2 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.0 | 0.2 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
| 0.0 | 0.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.4 | 33.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 7.8 | 31.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 7.0 | 49.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 5.8 | 23.2 | GO:0097001 | ceramide binding(GO:0097001) |
| 5.6 | 16.7 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 5.5 | 32.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 4.8 | 14.5 | GO:0017129 | triglyceride binding(GO:0017129) |
| 4.5 | 13.5 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 4.0 | 19.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 3.9 | 11.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 3.9 | 46.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 3.8 | 11.4 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 3.8 | 18.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 3.8 | 226.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 3.7 | 15.0 | GO:0004802 | transketolase activity(GO:0004802) |
| 3.6 | 32.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 3.6 | 10.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 3.6 | 14.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 3.6 | 18.1 | GO:0004803 | transposase activity(GO:0004803) |
| 3.5 | 10.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 3.4 | 23.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 3.3 | 6.5 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 3.3 | 9.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 3.2 | 13.0 | GO:0004077 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 3.2 | 48.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 3.2 | 12.7 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 3.2 | 12.7 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 3.1 | 18.3 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 3.1 | 9.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 2.9 | 14.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 2.9 | 11.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 2.9 | 67.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 2.9 | 11.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 2.9 | 34.6 | GO:0008430 | selenium binding(GO:0008430) |
| 2.9 | 17.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 2.8 | 8.5 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 2.8 | 8.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 2.8 | 8.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 2.8 | 30.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 2.8 | 5.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 2.7 | 10.9 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 2.7 | 16.2 | GO:0030172 | troponin C binding(GO:0030172) |
| 2.7 | 2.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 2.6 | 102.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 2.6 | 15.6 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 2.6 | 15.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 2.6 | 36.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 2.6 | 12.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 2.6 | 15.4 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 2.5 | 7.6 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 2.5 | 20.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 2.5 | 7.5 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 2.4 | 7.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 2.4 | 14.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 2.4 | 14.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 2.3 | 23.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 2.3 | 13.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 2.3 | 9.2 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 2.3 | 6.9 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 2.3 | 9.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 2.2 | 8.9 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 2.2 | 20.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 2.2 | 6.6 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 2.2 | 8.7 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 2.1 | 6.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 2.1 | 6.4 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 2.1 | 2.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 2.1 | 8.4 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 2.1 | 6.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 2.1 | 14.5 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
| 2.0 | 8.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 2.0 | 6.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 2.0 | 2.0 | GO:0080084 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 2.0 | 8.0 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 2.0 | 9.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 2.0 | 7.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
| 2.0 | 3.9 | GO:0070052 | collagen V binding(GO:0070052) |
| 1.9 | 7.7 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 1.9 | 7.7 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
| 1.9 | 7.6 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 1.9 | 5.7 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 1.9 | 5.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 1.9 | 3.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 1.9 | 3.7 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 1.8 | 7.4 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 1.8 | 7.3 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 1.8 | 10.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 1.8 | 7.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 1.8 | 10.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 1.8 | 3.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 1.8 | 10.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 1.8 | 8.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 1.8 | 1.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 1.7 | 5.2 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 1.7 | 6.9 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 1.7 | 8.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 1.7 | 12.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 1.7 | 15.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.7 | 17.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 1.7 | 6.8 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 1.7 | 15.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 1.7 | 8.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 1.7 | 15.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 1.7 | 6.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 1.7 | 5.0 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 1.7 | 16.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 1.7 | 16.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
| 1.6 | 6.5 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 1.6 | 3.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 1.6 | 3.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 1.6 | 19.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 1.6 | 6.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 1.6 | 4.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 1.6 | 4.7 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 1.6 | 11.0 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 1.6 | 17.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
| 1.6 | 17.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 1.5 | 4.6 | GO:0052815 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 1.5 | 19.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 1.5 | 3.0 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 1.5 | 6.0 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 1.5 | 13.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 1.5 | 4.5 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 1.5 | 13.5 | GO:0043426 | MRF binding(GO:0043426) |
| 1.5 | 17.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 1.5 | 13.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 1.4 | 13.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 1.4 | 5.8 | GO:0035473 | lipase binding(GO:0035473) |
| 1.4 | 5.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 1.4 | 2.9 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 1.4 | 4.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 1.4 | 5.7 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 1.4 | 29.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 1.4 | 8.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 1.4 | 5.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 1.4 | 11.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 1.4 | 6.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.4 | 6.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 1.4 | 6.9 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 1.4 | 1.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 1.3 | 4.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 1.3 | 10.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 1.3 | 9.4 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 1.3 | 8.0 | GO:0004359 | glutaminase activity(GO:0004359) |
| 1.3 | 37.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 1.3 | 14.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 1.3 | 6.6 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.3 | 5.3 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 1.3 | 5.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 1.3 | 6.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 1.3 | 6.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 1.3 | 31.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 1.3 | 8.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 1.3 | 5.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
| 1.3 | 6.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 1.3 | 7.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 1.2 | 6.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 1.2 | 4.9 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 1.2 | 3.7 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 1.2 | 6.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 1.2 | 3.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 1.2 | 3.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 1.2 | 3.6 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 1.2 | 10.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 1.2 | 4.7 | GO:0047708 | biotinidase activity(GO:0047708) |
| 1.2 | 28.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 1.2 | 23.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 1.2 | 5.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 1.2 | 9.3 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 1.1 | 3.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 1.1 | 11.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 1.1 | 4.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 1.1 | 10.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 1.1 | 2.2 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
| 1.1 | 13.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 1.1 | 6.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 1.1 | 6.6 | GO:0090554 | phosphatidylcholine transporter activity(GO:0008525) phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 1.1 | 6.6 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 1.1 | 3.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 1.1 | 5.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 1.1 | 8.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 1.1 | 6.5 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 1.1 | 2.2 | GO:0070405 | ammonium ion binding(GO:0070405) |
| 1.1 | 5.3 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 1.1 | 3.2 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 1.1 | 9.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 1.0 | 5.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 1.0 | 7.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 1.0 | 4.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 1.0 | 7.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 1.0 | 35.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 1.0 | 23.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 1.0 | 8.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 1.0 | 13.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 1.0 | 4.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 1.0 | 6.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 1.0 | 138.4 | GO:0003823 | antigen binding(GO:0003823) |
| 1.0 | 6.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 1.0 | 2.9 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 1.0 | 30.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.9 | 2.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.9 | 5.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.9 | 3.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.9 | 1.9 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.9 | 3.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.9 | 4.6 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.9 | 5.4 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.9 | 19.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.9 | 3.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.9 | 3.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.9 | 2.6 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.9 | 3.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.9 | 3.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.9 | 5.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.9 | 5.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.9 | 2.6 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.9 | 4.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.9 | 3.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.9 | 8.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.9 | 4.3 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.9 | 6.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.9 | 6.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.9 | 3.4 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.8 | 52.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.8 | 3.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.8 | 10.9 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.8 | 2.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.8 | 9.1 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.8 | 3.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.8 | 25.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.8 | 12.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.8 | 3.2 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.8 | 6.5 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.8 | 13.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.8 | 7.2 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.8 | 3.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.8 | 9.6 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.8 | 2.4 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.8 | 4.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.8 | 25.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.8 | 3.9 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.8 | 3.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.8 | 3.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.8 | 4.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.8 | 8.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.8 | 2.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.8 | 3.0 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.7 | 2.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
| 0.7 | 3.7 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.7 | 2.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.7 | 11.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.7 | 2.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.7 | 10.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.7 | 2.9 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.7 | 4.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.7 | 2.9 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.7 | 2.9 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.7 | 10.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.7 | 10.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.7 | 2.1 | GO:0033265 | choline binding(GO:0033265) |
| 0.7 | 4.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.7 | 3.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.7 | 2.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.7 | 9.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.7 | 8.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.7 | 2.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.7 | 4.8 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.7 | 20.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.7 | 24.0 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.7 | 8.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.7 | 6.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.7 | 9.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.7 | 3.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.7 | 10.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.7 | 8.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.7 | 6.0 | GO:0010851 | cyclase regulator activity(GO:0010851) |
| 0.7 | 4.7 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
| 0.7 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.7 | 2.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.7 | 4.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.7 | 27.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.7 | 2.0 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.6 | 2.6 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.6 | 1.9 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.6 | 10.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.6 | 6.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.6 | 11.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.6 | 1.9 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.6 | 3.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.6 | 7.0 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.6 | 6.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.6 | 2.5 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.6 | 5.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.6 | 19.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.6 | 1.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.6 | 1.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.6 | 20.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.6 | 3.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.6 | 3.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.6 | 15.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.6 | 3.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.6 | 7.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.6 | 4.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.6 | 59.7 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.6 | 1.8 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.6 | 7.7 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
| 0.6 | 11.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.6 | 6.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.6 | 4.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.6 | 5.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.6 | 4.6 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.6 | 1.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.6 | 4.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.6 | 2.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 0.6 | 3.4 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.6 | 13.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.6 | 6.2 | GO:0016594 | glycine binding(GO:0016594) |
| 0.6 | 7.9 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
| 0.6 | 5.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.6 | 2.8 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.6 | 20.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.6 | 2.2 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.6 | 4.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.5 | 8.8 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.5 | 1.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.5 | 11.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.5 | 4.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.5 | 1.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.5 | 15.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.5 | 8.5 | GO:0016502 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.5 | 7.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.5 | 9.6 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.5 | 1.6 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.5 | 2.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.5 | 4.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.5 | 5.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.5 | 10.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.5 | 4.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.5 | 14.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.5 | 6.6 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.5 | 5.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.5 | 2.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.5 | 3.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.5 | 4.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.5 | 3.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.5 | 2.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.5 | 34.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.5 | 5.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.5 | 1.0 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.5 | 12.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.5 | 6.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.5 | 1.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.5 | 8.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.5 | 1.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.5 | 7.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.5 | 6.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.5 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.5 | 3.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.5 | 7.1 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.5 | 5.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.5 | 100.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.5 | 3.7 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.5 | 3.7 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.5 | 14.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.5 | 1.4 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.5 | 1.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.5 | 6.3 | GO:0019864 | IgG binding(GO:0019864) |
| 0.4 | 32.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.4 | 1.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.4 | 4.9 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.4 | 10.9 | GO:0005521 | lamin binding(GO:0005521) |
| 0.4 | 1.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.4 | 1.3 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.4 | 3.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.4 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.4 | 2.5 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.4 | 3.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.4 | 1.7 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.4 | 1.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.4 | 3.7 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.4 | 19.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.4 | 3.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.4 | 4.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.4 | 4.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.4 | 8.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.4 | 19.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.4 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.4 | 7.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.4 | 1.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.4 | 10.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.4 | 1.2 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.4 | 6.8 | GO:0070513 | death domain binding(GO:0070513) |
| 0.4 | 8.3 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.4 | 6.0 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.4 | 1.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.4 | 5.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.4 | 4.8 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.4 | 23.4 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.4 | 5.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.4 | 1.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.4 | 12.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
| 0.4 | 31.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.4 | 2.8 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.4 | 5.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.4 | 2.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.3 | 2.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 1.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.3 | 7.9 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.3 | 9.0 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
| 0.3 | 1.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.3 | 3.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.3 | 2.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 7.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.3 | 1.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.3 | 2.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.3 | 2.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.3 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.3 | 1.3 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.3 | 4.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.3 | 1.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.3 | 2.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.3 | 1.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.3 | 18.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.3 | 30.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.3 | 1.9 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.3 | 1.9 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.3 | 4.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.3 | 7.1 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.3 | 2.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.3 | 5.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.3 | 1.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.3 | 2.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.3 | 4.8 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.3 | 26.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.3 | 5.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.3 | 1.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.3 | 21.3 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.3 | 2.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.3 | 2.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.3 | 10.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.3 | 2.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 6.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.3 | 2.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.3 | 1.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.3 | 8.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.3 | 5.1 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 2.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.3 | 2.1 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.3 | 2.9 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.3 | 1.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.3 | 0.8 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.3 | 2.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.3 | 0.8 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.2 | 5.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.2 | 1.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.2 | 19.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 0.7 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.2 | 4.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.2 | 1.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.2 | 12.5 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 3.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 1.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.2 | 7.3 | GO:0032451 | demethylase activity(GO:0032451) |
| 0.2 | 0.7 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.2 | 2.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 0.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.2 | 3.2 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.2 | 2.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.2 | 4.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.2 | 15.2 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
| 0.2 | 6.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 4.9 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.2 | 12.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.2 | 7.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 4.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.2 | 2.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.2 | 0.9 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.2 | 1.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 3.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 11.7 | GO:0005518 | collagen binding(GO:0005518) |
| 0.2 | 0.6 | GO:0052830 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol pentakisphosphate phosphatase activity(GO:0052827) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.2 | 3.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 2.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.2 | 1.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.2 | 5.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.2 | 0.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 2.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.2 | 1.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 1.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 3.5 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.2 | 5.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.2 | 2.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.2 | 3.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 9.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 2.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.2 | 1.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.2 | 5.8 | GO:0017022 | myosin binding(GO:0017022) |
| 0.2 | 2.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.2 | 4.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.2 | 0.9 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.2 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.2 | 3.9 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.2 | 1.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.2 | 0.5 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.2 | 0.7 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.2 | 1.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.2 | 3.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.2 | 1.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.2 | 0.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.2 | 0.5 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.2 | 0.5 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.1 | 2.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 3.1 | GO:0015276 | ligand-gated ion channel activity(GO:0015276) ligand-gated channel activity(GO:0022834) |
| 0.1 | 2.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 0.7 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.1 | 2.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 0.8 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.1 | 0.7 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.1 | 0.5 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.1 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 1.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 15.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.1 | 0.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 4.1 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 1.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 4.3 | GO:0046934 | phosphatidylinositol 3-kinase activity(GO:0035004) phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
| 0.1 | 53.6 | GO:0099600 | transmembrane receptor activity(GO:0099600) |
| 0.1 | 39.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 0.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.1 | 0.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 0.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.1 | 1.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.1 | 0.9 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.1 | 146.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.1 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.1 | 0.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.1 | 0.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.1 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.1 | 0.8 | GO:0001848 | complement binding(GO:0001848) |
| 0.1 | 0.4 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.1 | 6.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 0.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.1 | 0.4 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.1 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.1 | 0.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 0.7 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
| 0.0 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
| 0.0 | 0.5 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.0 | 6.4 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.0 | 0.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.0 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 1.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 1.1 | 9.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 1.1 | 53.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 1.1 | 6.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 1.0 | 49.3 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.9 | 15.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.8 | 79.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.8 | 35.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.7 | 54.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.7 | 22.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.7 | 6.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.6 | 37.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.6 | 8.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.6 | 28.1 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.6 | 17.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.6 | 4.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.6 | 14.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.6 | 12.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.6 | 28.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.6 | 9.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.6 | 29.3 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.5 | 25.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.5 | 10.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.5 | 13.8 | PID EPO PATHWAY | EPO signaling pathway |
| 0.5 | 14.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.5 | 20.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.5 | 61.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.5 | 2.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.5 | 98.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.5 | 19.1 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.5 | 13.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.5 | 22.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.4 | 2.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.4 | 4.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.4 | 21.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.4 | 1.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.4 | 7.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.4 | 9.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.4 | 1.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.4 | 5.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.4 | 10.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.4 | 12.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.4 | 6.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.4 | 2.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.4 | 3.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.4 | 22.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.4 | 1.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.3 | 19.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.3 | 8.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.3 | 2.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.3 | 21.0 | PID BMP PATHWAY | BMP receptor signaling |
| 0.3 | 8.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.3 | 13.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.3 | 12.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.3 | 6.7 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.3 | 7.9 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.3 | 1.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.3 | 71.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.3 | 2.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 3.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.3 | 6.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 5.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 1.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.2 | 1.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 4.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 37.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 6.3 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.2 | 4.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.2 | 4.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 2.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 1.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.2 | 1.5 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.2 | 2.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.2 | 5.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 2.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 42.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 5.7 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 2.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 1.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 2.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 3.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 2.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 2.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 1.3 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 2.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.0 | 1.7 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
| 0.0 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.8 | 99.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 3.3 | 33.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 2.8 | 52.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 2.8 | 30.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.7 | 35.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 1.6 | 40.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 1.6 | 38.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 1.5 | 41.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 1.5 | 6.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 1.5 | 20.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 1.4 | 22.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 1.4 | 2.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 1.4 | 6.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 1.3 | 21.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 1.2 | 17.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 1.1 | 105.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 1.1 | 54.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 1.1 | 21.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 1.0 | 16.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 1.0 | 39.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 1.0 | 2.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
| 1.0 | 10.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 1.0 | 29.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 1.0 | 9.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 1.0 | 19.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.9 | 29.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.9 | 6.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.9 | 5.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.9 | 12.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.9 | 34.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.9 | 14.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.9 | 0.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.9 | 13.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.9 | 17.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.8 | 11.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.8 | 3.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.8 | 15.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.8 | 12.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.8 | 6.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.8 | 5.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.8 | 7.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.8 | 2.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.7 | 32.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.7 | 16.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.7 | 5.7 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.7 | 24.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.7 | 14.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.7 | 19.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.7 | 29.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.7 | 11.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.7 | 29.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.7 | 24.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.6 | 5.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.6 | 30.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.6 | 9.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.6 | 7.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.6 | 19.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.6 | 12.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.6 | 272.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.6 | 32.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.6 | 17.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.6 | 13.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.6 | 34.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.6 | 11.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.6 | 24.2 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.6 | 8.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.5 | 5.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.5 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.5 | 3.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.5 | 6.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.5 | 133.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.5 | 16.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.5 | 3.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.5 | 6.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.5 | 16.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.5 | 13.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.5 | 6.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.5 | 1.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.5 | 34.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.5 | 5.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.5 | 7.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.4 | 9.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.4 | 3.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.4 | 8.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.4 | 6.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.4 | 6.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.4 | 6.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.4 | 8.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.4 | 1.6 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.4 | 8.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.4 | 7.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.4 | 6.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 8.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.4 | 4.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.4 | 11.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.4 | 7.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.4 | 2.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.3 | 6.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.3 | 7.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.3 | 12.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.3 | 4.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.3 | 4.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.3 | 10.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.3 | 4.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.3 | 13.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.3 | 3.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.3 | 39.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.3 | 2.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.3 | 3.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.3 | 16.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.3 | 11.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.3 | 20.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.3 | 3.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.3 | 1.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.3 | 3.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.3 | 1.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.3 | 13.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.3 | 6.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.2 | 2.7 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.2 | 1.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.2 | 3.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.2 | 9.1 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.2 | 25.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.2 | 3.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 3.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.2 | 4.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 3.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 3.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.2 | 4.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.2 | 2.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 1.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 3.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 2.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.2 | 2.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.2 | 0.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.1 | 2.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 2.6 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
| 0.1 | 1.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 8.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 1.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
| 0.1 | 0.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 1.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 1.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.1 | 0.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 1.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 1.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.0 | 1.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 2.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.0 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |